Material is the message. This exploration of mind, media and matter, process and substance, is the theme for Wallpaper* and StoneX’s ‘Material Alchemists’ exhibition, running at the Triennale di ...

“PTRME’s top goal is to create a cooperative ecosystem in which researchers can commercialize their biotechnology and regenerative medicine solutions, create jobs and impact economic development—and ...

(Abstract #2241) IO170, also developed using IO Biotech’s T-win ® platform, demonstrated significant tumor growth inhibition in breast and prostate cancer mouse models. The TGF- β-directed ...

Introduction: The incorporation of microalgae in food products is dependent on their volatile profiles, which significantly influence their organoleptic characteristics and, consequently, consumer ...

Flagship Pioneering unveiled its latest biotechnology startup on Thursday, a company aiming to map the progression of diseases and tailor medicines to stages of a patient’s journey. Called Etiome, the ...

Young is one of more than 1,000 dog owners participating in a first-of-its-kind clinical trial at more than 70 facilities around the country and spearheaded by Bay Area biotech company Loyal.

AstraZeneca, Tempus and AI-focused biotech Pathos will all be able to use the completed model for their own R&D work. The idea is that the model can be used to “gather biological and clinical ...

The Biotechnology Master of Science degree program provides students with advanced coursework in biotechnical and biomolecular sciences. Graduates are prepared for positions in research, and ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare.

Paul Stoffels, the former Johnson & Johnson executive who took over as CEO of Galapagos three years ago, is exiting the biotech. Stoffels leaves as Galapagos separates into two entities, one that will ...

Late last year, doc­tors in­ject­ed an ex­per­i­men­tal CRISPR ther­a­py in­to the brain of a 9-year-old boy with a rare neu­rode­vel­op­men­tal con­di­tion that can cause in­tel ...

Investing.com -- Biotech stocks climbed Monday after new FDA Commissioner Dr. Marty Makary laid out a clear and collaborative regulatory strategy that analysts say bodes well for drug developers.